This inventor holds 1 USPTO granted patent. Top assignee: Redona Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Anna M Ericsson: Innovator in RNA-Targeting Compounds
Introduction
Anna M Ericsson is a notable inventor based in Shrewsbury, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of compounds that target RNA-binding proteins or RNA-modifying proteins. Her innovative work has the potential to impact various therapeutic areas.
Latest Patents
Anna holds a patent for her invention related to compounds represented by Formula (I) or pharmaceutically acceptable salts thereof. This invention includes compositions comprising these compounds and methods for their preparation and use. The details of the variables are described in her patent documentation. She has 1 patent to her name.
Career Highlights
Anna is currently associated with Redona Therapeutics, Inc., where she continues to advance her research and development efforts. Her work focuses on creating novel therapeutic solutions that leverage her expertise in RNA-targeting compounds.
Collaborations
Throughout her career, Anna has collaborated with esteemed colleagues, including Shomir Ghosh and Darren Martin Harvey. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Anna M Ericsson is a pioneering inventor whose work in RNA-targeting compounds showcases her commitment to advancing biotechnology. Her contributions are poised to make a significant impact in the field of therapeutics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile